SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 15.96
-0.26 (-1.60%)
Nov 2, 2026, 4:28 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 893.73 million as of November 2, 2026. It is the 25,549th most valuable company in the world and the 316th biggest in Sweden. Its market cap has decreased by 30.75% in one year.
Market Cap
893.73M
Enterprise Value
880.43M
Revenue
n/a
Global Rank
Country Rank
#316 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 893.73M, an increase of 1,301.89%. That is a compound annual growth rate of 29.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 893.73M | -25.85% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.54B |
| Genovis AB (publ.) | 1.46B |
| Flerie AB | 1.21B |
| Medivir AB | 967.26M |
| Infant Bacterial Therapeutics AB | 885.07M |
| AlzeCure Pharma AB | 882.54M |
| Oncopeptides AB | 661.32M |
| Xspray Pharma AB | 559.52M |